Imanova Secures License from Cerveau Technologies, Inc. to Manufacture Investigational Tau Ligand Posted on June 30, 2017February 22, 2022 by Cerveau Technologies
Cerveau Technologies, Inc. Announces Collaboration with NYU Langone Medical Center Posted on June 26, 2017February 22, 2022 by Cerveau Technologies
Cerveau Technologies, Inc. Announces FDA Acceptance of Investigational New Drug (IND) for Tau Imaging Agent MK-6240 Posted on June 16, 2017February 22, 2022 by Cerveau Technologies
Collaborators Login